More than 130 clinical trials are open at Providence Cancer Institute
Providence Cancer Institute is currently conducting more than 130 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.
Immunotherapy studies for advanced melanoma
Providence Cancer Institute,
an international leader in melanoma research and treatment, currently has more than 10 studies of investiga-tional and FDA-approved immunotherapies open for people with advanced melanoma, including two new studies: